Lack of BDNF expression through promoter IV disturbs expression of monoamine genes in the frontal cortex and hippocampus

Neuroscience

Volumn 260, Issue , 2014, Pages 265-275

  Sakata, K ^a   Duke, S M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

BDNF; Frontal cortex; Gene expression; Hippocampus; Monoamine systems; Promoter IV

Indexed keywords

ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; MESSENGER RNA; MONOAMINE; SEROTONIN RECEPTOR; SEROTONIN RECEPTOR 1B; SEROTONIN RECEPTOR 2A; SEROTONIN RECEPTOR 5B; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; HIPPOCAMPUS; MALE; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ADR; ADRENERGIC RECEPTOR; BDNF; BRAIN-DERIVED NEUROTROPHIC FACTOR; CT; CYCLE THRESHOLD; DAT; DOPAMINE D2 RECEPTOR; DOPAMINE D4 RECEPTOR; DOPAMINE TRANSPORTER; DRD2; DRD4; EDTA; EPSC; ETHYLENEDIAMINETETRAACETIC ACID; EXCITATORY POSTSYNAPTIC CURRENT; FALSE DISCOVERY RATE; FC; FDR; FRONTAL CORTEX; GENE EXPRESSION; HIP; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC CURRENT; IPSC; KIV; KNOCK-IN PROMOTER IV; MONOAMINE SYSTEMS; NET; NOREPINEPHRINE TRANSPORTER; PROMOTER IV; QRT-PCR; QUANTITATIVE REVERSE-TRANSCRIPTION POLYMERASE CHAIN REACTION; SE; SELECTIVE SEROTONIN REUPTAKE INHIBITOR; SSRI; STANDARD ERROR OF MEAN; TH; TPH; TRYPTOPHAN HYDROXYLASE; TYROSINE HYDROXYLASE; WILD-TYPE; WT;

ANIMALS; BIOGENIC MONOAMINES; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PROMOTER REGIONS, GENETIC;

EID: 84892494812     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.12.013     Document Type: Article

References (100)

1. Abi-Saab W.M., Bubser M., Roth R.H., Deutch A.Y. 5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology 1999, 20:92-96.
2. Abumaria N., Ribic A., Anacker C., Fuchs E., Flugge G. Stress upregulates TPH1 but not TPH2 mRNA in the rat dorsal raphe nucleus: identification of two TPH2 mRNA splice variants. Cell Mol Neurobiol 2008, 28:331-342.
3. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 1997, 36:589-599.
4. Aid T., Kazantseva A., Piirsoo M., Palm K., Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 2007, 85:525-535.
5. Arango V., Ernsberger P., Sved A.F., Mann J.J. Quantitative autoradiography of alpha 1- and alpha 2-adrenergic receptors in the cerebral cortex of controls and suicide victims. Brain Res 1993, 630:271-282.
6. Arnsten A.F., Murphy B., Merchant K. The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys. Neuropsychopharmacology 2000, 23:405-410.
7. Benjamini Y., Hockberg T. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 1995, 289-300.
8. Boldrini M., Underwood M.D., Mann J.J., Arango V. More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res 2005, 1041:19-28.
9. Boschert U., Amara D.A., Segu L., Hen R. The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience 1994, 58:167-182.
10. Brain Gene Expression Map (BGEM) SJR (2013). http://www.stjudebgem.org/web/view/probe/viewProbeDetails.php?id=389.
11. Bristow L.J., Kramer M.S., Kulagowski J., Patel S., Ragan C.I., Seabrook G.R. Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist. Trends Pharmacol Sci 1997, 18:186-188.
12. Ceci A., Brambilla A., Duranti P., Grauert M., Grippa N., Borsini F. Effect of antipsychotic drugs and selective dopaminergic antagonists on dopamine-induced facilitatory activity in prelimbic cortical pyramidal neurons. An in vitro study. Neuroscience 1999, 93:107-115.
13. Chamas F.M., Underwood M.D., Arango V., Serova L., Kassir S.A., Mann J.J., Sabban E.L. Immobilization stress elevates tryptophan hydroxylase mRNA and protein in the rat raphe nuclei. Biol Psychiatry 2004, 55:278-283.
14. Corrigan M.H., Gallen C.C., Bonura M.L., Merchant K.M. Effectiveness of the selective D4 antagonist sonepiprazole in schizophrenia: a placebo-controlled trial. Biol Psychiatry 2004, 55:445-451.
15. Day H.E., Campeau S., Watson S.J., Akil H. Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat 1997, 13:115-139.
16. De Paermentier F., Mauger J.M., Lowther S., Crompton M.R., Katona C.L., Horton R.W. Brain alpha-adrenoceptors in depressed suicides. Brain Res 1997, 757:60-68.
17. Doze V.A., Handel E.M., Jensen K.A., Darsie B., Luger E.J., Haselton J.R., Talbot J.N., Rorabaugh B.R. Alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse. Brain Res 2009, 1285:148-157.
18. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997, 54:597-606.
19. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
20. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:804-815.
21. Fink K.B., Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 2007, 59:360-417.
22. Fuchikami M., Morinobu S., Kurata A., Yamamoto S., Yamawaki S. Single immobilization stress differentially alters the expression profile of transcripts of the brain-derived neurotrophic factor (BDNF) gene and histone acetylation at its promoters in the rat hippocampus. Int J Neuropsychopharmacol 2009, 12:73-82.
23. Gasbarri A., Verney C., Innocenzi R., Campana E., Pacitti C. Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Res 1994, 668:71-79.
24. Goldman-Rakic P.S., Leranth C., Williams S.M., Mons N., Geffard M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci U S A 1989, 86:9015-9019.
25. Grailhe R., Grabtree G.W., Hen R. Human 5-HT(5) receptors: the 5-HT(5A) receptor is functional but the 5-HT(5B) receptor was lost during mammalian evolution. Eur J Pharmacol 2001, 418:157-167.
26. Grobin A.C., Deutch A.Y. Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. J Pharmacol Exp Ther 1998, 285:350-357.
27. Gross-Isseroff R., Dillon K.A., Fieldust S.J., Biegon A. Autoradiographic analysis of alpha 1-noradrenergic receptors in the human brain postmortem. Effect of suicide. Arch Gen Psychiatry 1990, 47:1049-1053.
28. Gupta M.K., Papay R.S., Jurgens C.W., Gaivin R.J., Shi T., Doze V.A., Perez D.M. Alpha1-Adrenergic receptors regulate neurogenesis and gliogenesis. Mol Pharmacol 2009, 76:314-326.
29. Hamon M., Bourgoin S., Hery F., Ternaux J.P., Glowinski J. In vivo and in vitro activation of soluble tryptophan hydroxylase from rat brainstem. Nature 1976, 260:61-63.
30. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci 2005, 25:372-383.
31. Hing B., Davidson S., Lear M., Breen G., Quinn J., McGuffin P., MacKenzie A. A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity. Biol Psychiatry 2012, 71:618-626.
32. Iyer R.N., Bradberry C.W. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J Pharmacol Exp Ther 1996, 277:40-47.
33. Jacobs B.L., Azmitia E.C. Structure and function of the brain serotonin system. Physiol Rev 1992, 72:165-229.
34. Jha S., Dong B., Sakata K. Enriched environment treatment reverses depression-like behavior and restores reduced hippocampal neurogenesis and protein levels of brain-derived neurotrophic factor in mice lacking its expression through promoter IV. Transl Psychiatry 2011, 1:e40.
35. Keller S., Sarchiapone M., Zarrilli F., Videtic A., Ferraro A., Carli V., Sacchetti S., Lembo F., Angiolillo A., Jovanovic N., Pisanti F., Tomaiuolo R., Monticelli A., Balazic J., Roy A., Marusic A., Cocozza S., Fusco A., Bruni C.B., Castaldo G., Chiariotti L. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010, 67:258-267.
36. Kim S., Zavitsanou K., Gurguis G., Webster M.J. Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: exploration of drug targets through the Stanley Neuropathology Integrative Database. Eur Neuropsychopharmacol 2012, 22:683-694.
37. Klein A.B., Santini M.A., Aznar S., Knudsen G.M., Rios M. Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice. Neuroscience 2010, 169:1007-1016.
38. Kulkarni V.A., Jha S., Vaidya V.A. Depletion of norepinephrine decreases the proliferation, but does not influence the survival and differentiation, of granule cell progenitors in the adult rat hippocampus. Eur J Neurosci 2002, 16:2008-2012.
39. Lahti R.A., Roberts R.C., Cochrane E.V., Primus R.J., Gallager D.W., Conley R.R., Tamminga C.A. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study. Mol Psychiatry 1998, 3:528-533.
40. Lambe E.K., Goldman-Rakic P.S., Aghajanian G.K. Serotonin induces EPSCs preferentially in layer V pyramidal neurons of the frontal cortex in the rat. Cereb Cortex 2000, 10:974-980.
41. Lauzon N.M., Laviolette S.R. Dopamine D4-receptor modulation of cortical neuronal network activity and emotional processing: Implications for neuropsychiatric disorders. Behav Brain Res 2010, 208:12-22.
42. Lavergne F., Jay T.M. A new strategy for antidepressant prescription. Front Neurosci 2010, 4:192.
43. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005, 6:312-324.
44. Leysen J.E. 5-HT2 receptors. Curr Drug Targets CNS Neurol Disord 2004, 3:11-26.
45. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
46. Lopez-Figueroa A.L., Norton C.S., Lopez-Figueroa M.O., Armellini-Dodel D., Burke S., Akil H., Lopez J.F., Watson S.J. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol Psychiatry 2004, 55:225-233.
47. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 1998, 44:151-162.
48. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., Wihler C., Koliatsos V.E., Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 1999, 96:15239-15244.
49. Malagie I., Trillat A.C., Bourin M., Jacquot C., Hen R., Gardier A.M. 5-HT1B autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex. J Neurochem 2001, 76:865-871.
50. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000, 20:9104-9110.
51. Metsis M., Timmusk T., Arenas E., Persson H. Differential usage of multiple brain-derived neurotrophic factor promoters in the rat brain following neuronal activation. Proc Natl Acad Sci U S A 1993, 90:8802-8806.
52. Miyamoto S., Duncan G.E., Marx C.E., Lieberman J.A. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 2005, 10:79-104.
53. Morikawa H., Manzoni O.J., Crabbe J.C., Williams J.T. Regulation of central synaptic transmission by 5-HT(1B) auto- and heteroreceptors. Mol Pharmacol 2000, 58:1271-1278.
54. Mrzljak L., Bergson C., Pappy M., Huff R., Levenson R., Goldman-Rakic P.S. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 1996, 381:245-248.
55. Nalepa I., Kreiner G., Kowalska M., Sanak M., Zelek-Molik A., Vetulani J. Repeated imipramine and electroconvulsive shock increase alpha 1A-adrenoceptor mRNA level in rat prefrontal cortex. Eur J Pharmacol 2002, 444:151-159.
56. Naughton M., Mulrooney J.B., Leonard B.E. A review of the role of serotonin receptors in psychiatric disorders. Hum Psychopharmacol 2000, 15:397-415.
57. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
58. Onn S.P., Wang X.B., Lin M., Grace A.A. Dopamine D1 and D4 receptor subtypes differentially modulate recurrent excitatory synapses in prefrontal cortical pyramidal neurons. Neuropsychopharmacology 2006, 31:318-338.
59. Perez D.M., Doze V.A. Cardiac and neuroprotection regulated by alpha(1)-adrenergic receptor subtypes. J Recept Signal Transduct Res 2011, 31:98-110.
60. Reiner A., Wang H.B., Del Mar N., Sakata K., Yoo W., Deng Y.P. BDNF may play a differential role in the protective effect of the mGluR2/3 agonist LY379268 on striatal projection neurons in R6/2 Huntington's disease mice. Brain Res 2012, 1473:161-172.
61. Retaux S., Besson M.J., Penit-Soria J. Synergism between D1 and D2 dopamine receptors in the inhibition of the evoked release of [3H]GABA in the rat prefrontal cortex. Neuroscience 1991, 43:323-329.
62. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., Lechan R.M., Jaenisch R. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 2001, 15:1748-1757.
63. Rios M., Lambe E.K., Liu R., Teillon S., Liu J., Akbarian S., Roffler-Tarlov S., Jaenisch R., Aghajanian G.K. Severe deficits in 5-HT2A -mediated neurotransmission in BDNF conditional mutant mice. J Neurobiol 2006, 66:408-420.
64. Roberts D.A., Balderson D., Pickering-Brown S.M., Deakin J.F., Owen F. The abundance of mRNA for dopamine D2 receptor isoforms in brain tissue from controls and schizophrenics. Brain Res Mol Brain Res 1994, 25:173-175.
65. Roth B.L., Tandra S., Burgess L.H., Sibley D.R., Meltzer H.Y. D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology (Berl) 1995, 120:365-368.
66. Roth T.L., Lubin F.D., Funk A.J., Sweatt J.D. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 2009, 65:760-769.
67. Rubinstein M., Cepeda C., Hurst R.S., Flores-Hernandez J., Ariano M.A., Falzone T.L., Kozell L.B., Meshul C.K., Bunzow J.R., Low M.J., Levine M.S., Grandy D.K. Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J Neurosci 2001, 21:3756-3763.
68. Sakata K. Brain derived neurotrophic factor and major depression. Neurobiology of depression, frontiers in neuroscience 2011, 391-417. CRC Press, Florida. F. López-Muñoz (Ed.).
69. Sakata K., Jin L., Jha S. Lack of promoter IV-driven BDNF transcription results in depression-like behavior. Genes Brain Behav 2010, 9:712-721.
70. Sakata K., Martinowich K., Woo N.H., Schloesser R.J., Jimenez D.V., Ji Y., Shen L., Lu B. Role of activity-dependent BDNF expression in hippocampal-prefrontal cortical regulation of behavioral perseverance. Proc Natl Acad Sci U S A 2013, 110:15103-15108.
71. Sakata K., Mastin J.R., Duke S.M., Vail M.G., Overacre A.E., Dong B.E., Jha S. Effects of antidepressant treatment on mice lacking brain-derived neurotrophic factor expression through promoter IV. Eur J Neurosci 2013, 37:1863-1874.
72. Sakata K., Woo N.H., Martinowich K., Greene J.S., Schloesser R.J., Shen L., Lu B. Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex. Proc Natl Acad Sci U S A 2009, 106:5942-5947.
73. Santana N., Mengod G., Artigas F. Expression of alpha(1)-adrenergic receptors in rat prefrontal cortex: cellular co-localization with 5-HT(2A) receptors. Int J Neuropsychopharmacol 2013, 16:1139-1151.
74. Schmidt C.J., Fadayel G.M. The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur J Pharmacol 1995, 273:273-279.
75. Seeman P., Guan H.C., Van Tol H.H. Dopamine D4 receptors elevated in schizophrenia. Nature 1993, 365:441-445.
76. Sesack S.R., Snyder C.L., Lewis D.A. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol 1995, 363:264-280.
77. Shieh P.B., Hu S.C., Bobb K., Timmusk T., Ghosh A. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 1998, 20:727-740.
78. Siuciak J.A., Clark M.S., Rind H.B., Whittemore S.R., Russo A.F. BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain. J Neurosci Res 1998, 52:149-158.
79. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995, 15:1768-1777.
80. Stone E.A., Quartermain D. Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression. Biol Psychiatry 1999, 46:1287-1300.
81. Storey J.D., Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003, 100:9440-9445.
82. Tallerico T., Novak G., Liu I.S., Ulpian C., Seeman P. Schizophrenia: elevated mRNA for dopamine D2(Longer) receptors in frontal cortex. Brain Res Mol Brain Res 2001, 87:160-165.
83. Tao X., Finkbeiner S., Arnold D.B., Shaywitz A.J., Greenberg M.E. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998, 20:709-726.
84. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995, 270:593-598.
85. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006, 9:519-525.
86. Van Tol H.H., Bunzow J.R., Guan H.C., Sunahara R.K., Seeman P., Niznik H.B., Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991, 350:610-614.
87. Vetulani J., Antkiewicz-Michaluk L., Rokosz-Pelc A. Chronic administration of antidepressant drugs increases the density of cortical [3H]prazosin binding sites in the rat. Brain Res 1984, 310:360-362.
88. Vincent S.L., Khan Y., Benes F.M. Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex. J Neurosci 1993, 13:2551-2564.
89. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Voits M., Fink H., Bader M. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003, 299:76.
90. Wang X., Zhong P., Yan Z. Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J Neurosci 2002, 22:9185-9193.
91. Warner-Schmidt J.L., Chen E.Y., Zhang X., Marshall J.J., Morozov A., Svenningsson P., Greengard P. A role for p11 in the antidepressant action of brain-derived neurotrophic factor. Biol Psychiatry 2010, 68:528-535.
92. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry 2003, 8:592-610.
93. Weiner D.M., Burstein E.S., Nash N., Croston G.E., Currier E.A., Vanover K.E., Harvey S.C., Donohue E., Hansen H.C., Andersson C.M., Spalding T.A., Gibson D.F., Krebs-Thomson K., Powell S.B., Geyer M.A., Hacksell U., Brann M.R. 5-hydroxytryptamine2A receptor inverse agonists as antipsychotics. J Pharmacol Exp Ther 2001, 299:268-276.
94. Wong J., Hyde T.M., Cassano H.L., Deep-Soboslay A., Kleinman J.E., Weickert C.S. Promoter specific alterations of brain-derived neurotrophic factor mRNA in schizophrenia. Neuroscience 2010, 169:1071-1084.
95. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., Jennes L. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 1995, 351:357-373.
96. Yuen E.Y., Yan Z. Dopamine D4 receptors regulate AMPA receptor trafficking and glutamatergic transmission in GABAergic interneurons of prefrontal cortex. J Neurosci 2009, 29:550-562.
97. Zhang K., Grady C.J., Tsapakis E.M., Andersen S.L., Tarazi F.I., Baldessarini R.J. Regulation of working memory by dopamine D4 receptor in rats. Neuropsychopharmacology 2004, 29:1648-1655.
98. Zhou F.M., Hablitz J.J. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 1999, 82:2989-2999.
99. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol Rev 1992, 44:401-458.
100. Zill P., Buttner A., Eisenmenger W., Muller J., Moller H.J., Bondy B. Predominant expression of tryptophan hydroxylase 1 mRNA in the pituitary: a postmortem study in human brain. Neuroscience 2009, 159:1274-1282.